Ericson, M. D., Freeman, K. T., Schnell, S. M., Fleming, K. A., & Haskell-Luevano, C. (2017). Structure-Activity Relationship Studies on a Macrocyclic Agouti-Related Protein (AGRP) Scaffold Reveal Agouti Signaling Protein (ASP) Residue Substitutions Maintain Melanocortin-4 Receptor Antagonist Potency and Result in Inverse Agonist Pharmacology at the Melanocortin-5 Receptor. J Med Chem.

Ericson, Mark D., Katie T. Freeman, Sathya M. Schnell, Katlyn A. Fleming, und Carrie Haskell-Luevano. "Structure-Activity Relationship Studies On a Macrocyclic Agouti-Related Protein (AGRP) Scaffold Reveal Agouti Signaling Protein (ASP) Residue Substitutions Maintain Melanocortin-4 Receptor Antagonist Potency and Result in Inverse Agonist Pharmacology At the Melanocortin-5 Receptor." J Med Chem 2017.

Ericson, Mark D., et al. "Structure-Activity Relationship Studies On a Macrocyclic Agouti-Related Protein (AGRP) Scaffold Reveal Agouti Signaling Protein (ASP) Residue Substitutions Maintain Melanocortin-4 Receptor Antagonist Potency and Result in Inverse Agonist Pharmacology At the Melanocortin-5 Receptor." J Med Chem 2017.